summary
Introduced
01/29/2026
01/29/2026
In Committee
02/10/2026
02/10/2026
Crossed Over
Passed
Dead
Introduced Session
104th General Assembly
Bill Summary
Amends the Department of Healthcare and Family Services Law. Requires the Department of Healthcare and Family Services to conduct a statewide one-year pilot program that studies the prevalence of cholestatic liver disorders associated with increased risk of end-stage liver disease among women ages 35 through 64 who are recipients of medical assistance. Requires the Department to collect the following information on study participants: (1) key demographics such as age, genetic predispositions, pre-existing conditions, and lifestyle factors that elevate the risk of developing cholestatic liver disorders; (2) the number or percentage of study participants who, despite being identified as high-risk, do not follow through with referrals or treatment recommendations; (3) the number of study participants who avoid referral and follow-up care or engage in treatment avoidance; and (4) any other relevant information or issues identified by the Department. Requires the Department to compile a report on its findings at the end of the one-year study and include (i) recommendations on how to increase awareness of cholestatic liver disorders through screenings, genetic testing, and collaboration with patient advocacy groups to raise public awareness and (ii) an analysis of strategies and funding to increase screening and genetic testing for cholestatic liver disorders. Provides that the Department shall submit the report to the General Assembly no later than December 31, 2028. Effective immediately.
AI Summary
This bill mandates that the Department of Healthcare and Family Services (DHFS) conduct a one-year statewide pilot program to study the prevalence of cholestatic liver disorders, which are liver conditions that can lead to end-stage liver disease, in women aged 35 to 64 who receive medical assistance. The program will collect data on participants' demographics, risk factors like genetic predispositions and pre-existing conditions, and their adherence to recommended screenings and treatments, noting any instances of treatment avoidance. Following the study, the DHFS will compile a report by December 31, 2028, for the General Assembly, which will include recommendations for increasing awareness of these disorders through screenings, genetic testing, and collaboration with patient advocacy groups, as well as an analysis of strategies and funding for enhanced screening and genetic testing.
Committee Categories
Budget and Finance
Sponsors (1)
Last Action
Assigned to Appropriations- Health and Human Services (on 02/10/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...